Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
217 hedge funds and large institutions have $1.16B invested in Natus Medical Inc in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 86 increasing their positions, 65 reducing their positions, and 28 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 65
18% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 28
2% more funds holding
Funds holding: 212 → 217 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less capital invested
Capital invested by funds: $1.22B → $1.16B (-$57.7M)
19% less call options, than puts
Call options by funds: $2.72M | Put options by funds: $3.36M
Top Buyers
Top Sellers
NTUS Hedge Fund Activity: Q2 2017 in Review
217 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2017, worth a combined $1.16B — down 4.7% from $1.22B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new NTUS positions and 28 closed out — a net gain of 5 holders — while 86 added to existing stakes and 65 trimmed.
The largest buyer was Confluence Investment Management, adding an estimated $13.1M. The largest seller was Lyon Street Capital, cutting an estimated $18.9M.
- 217 institutional investors held Natus Medical Inc (NTUS) as of Q2 2017, up from 212 in Q1 2017.
- Funds reported $1.16B of Natus Medical Inc stock for Q2 2017, down 4.7% quarter-over-quarter.
- 33 funds opened new Natus Medical Inc positions in Q2 2017 and 28 closed out, a net change of +5 holders.
- The largest Natus Medical Inc buyer in Q2 2017 was Confluence Investment Management, an estimated $13.1M added.
- The largest Natus Medical Inc seller in Q2 2017 was Lyon Street Capital, an estimated $18.9M sold.
Based on aggregated 13F filings for Q2 2017.